Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Post by FredTheVoiceon Oct 23, 2018 7:42am
112 Views
Post# 28853669

Light in six months...

Light in six months...I appreciate, big time, the light of SMART MITCH, but sorry, its your worst post since I read you. In six months, im pretty sure, we will come back to read your post and, the comment that will be the funniest will be: "people who put little money to try this investment few months ago and they will no longer touch it with a 20 feet pole again". 

That is, and you know, far from reality with a stock like TH. You know that your own target for the stock (12$ for the end of year) will be touched.....and you know as well, that their is a GREAT, BIG probability that on the next AGM in may, that this stock will beat the 52 HIGH of the year. That you know. WHY ? AND HOW ? For sure, we need, november approval of EGRIFTA new version; trend of sales gaining each month a good move upwards, Europe approval in february, and a good result for next quarter. AND YOU KNOW THAT IT IS ALL ACHIEVABLE. TH delievered in the last year. The stock price, actually, is just SHORT MOMENT DIVERSION.

You posts, even on the PLI board are always accompanied with a lot of wisdom.

Not this one. With all my respect.

FTV.


Bullboard Posts